Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2000Scandinavian Journal of Immunology

Immunotherapy of Crohn's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

VDVan DeventerAmsterdam UMC Location University of Amsterdam

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Van Deventer (2000) studied this question.

synapsesocial.com/papers/6a9c914e9beff30feb5d355chttps://doi.org/10.1046/j.1365-3083.2000.00657.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evidence that CD4<sup>+</sup>, but not CD8<sup>+</sup> T cells are responsible for murine interleukin‐2‐deficient colitis1995 · 140 citations
  2. 2Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.1996 · 124 citations
  3. 3Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.1997 · 90 citations
  4. 4Frequency of glucocorticoid resistance and dependency in Crohn's disease.1994 · 663 citations
  5. 5Antibodies to interleukin 12 abrogate established experimental colitis in mice.1995 · 1,348 citations